ARS Pharmaceuticals Inc
SPRY
NASDAQ
Biotechnology
$5.65
USD
-0.45 (-7.38%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $605.75M
Volume 5.0M
Price Target
$24.00 – $30.00
USD
The 2 analysts offering 1-year price forecasts have a max estimate of $30.00 and a min estimate of $24.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$27.00
Implied Upside
+377.9%
Analyst Covering
2
Consensus
Buy
Signal Quality
Consensus Freshness
100%
Most ratings are recent - from the last 3 months
Analyst Agreement
Moderate
Targets show moderate spread across analysts
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
2 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
2 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Roanna Ruiz | Leerink Partners | Buy | Maintained | 1 month ago | Plus | Plus | Plus |
Josh Schimmer | Evercore ISI Group | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
CCCC
C4 Therapeutics, Inc
$4.24
▲ +3.9%
EIKN
Eikon Therapeutics Inc
$11.05
▲ +7.0%
ARTV
Artiva Biotherapeutics Inc
$11.45
▲ +1.3%
PRME
Prime Medicine Inc
$3.09
▼ -2.5%
ZURA
Zura Bio Ltd
$5.57
▼ -1.1%
OVID
Ovid Therapeutics Inc
$2.83
▲ +1.1%
VSTM
Verastem Inc
$6.58
▼ -1.4%
ALT
Altimmune Inc
$2.94
▲ +2.1%
NVCT
Nuvectis Pharma Inc
$18.96
▼ -1.4%